A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sung Kwon | - |
dc.contributor.author | Yoon, Hong In | - |
dc.contributor.author | Yoon, Wan Soo | - |
dc.contributor.author | Cho, Jin Mo | - |
dc.contributor.author | Moon, Jangsup | - |
dc.contributor.author | Kim, Kyung Hwan | - |
dc.contributor.author | Kim, Se Hoon | - |
dc.contributor.author | Kim, Young Il | - |
dc.contributor.author | Kim, Young Zoon | - |
dc.contributor.author | Kim, Ho Sung | - |
dc.contributor.author | Dho, Yun Sik | - |
dc.contributor.author | Park, Jae Sung | - |
dc.contributor.author | Park, Ji Eun | - |
dc.contributor.author | Seo, Young Beom | - |
dc.contributor.author | Sung, Kyoung-Su | - |
dc.contributor.author | Song, Jin Ho | - |
dc.contributor.author | Wee, Chan Woo | - |
dc.contributor.author | Lee, Se Hoon | - |
dc.contributor.author | Lim, Do Hoon | - |
dc.contributor.author | Im, Jung Ho | - |
dc.contributor.author | Chang, Jong Hee | - |
dc.contributor.author | Han, Myun Hoon | - |
dc.contributor.author | Hong, Je Beom | - |
dc.contributor.author | Hwang, Kihwan | - |
dc.contributor.author | Park, Chul Kee | - |
dc.contributor.author | Lee, Youn Soo | - |
dc.contributor.author | Gwak, Ho-Shin | - |
dc.date.accessioned | 2022-07-08T08:40:32Z | - |
dc.date.available | 2022-07-08T08:40:32Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2020-04 | - |
dc.identifier.issn | 2288-2405 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145959 | - |
dc.description.abstract | Background The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part II of the survey, the aim of this study is to evaluate the national patterns of clinical practice for patients with diffuse midline glioma and meningioma. Methods A web-based survey was sent to all members of the KSNO by email. The survey included 4 questions of diffuse midline glioma and 6 questions of meningioma (including 2 case scenarios). All questions were developed by consensus of the Guideline Working Group. Results In the survey about diffuse midline glioma, 76% respondents performed histologic confirmation to identify H3K27M mutation on immunohistochemical staining or sequencing methods. For treatment of diffuse midline glioma, respondents preferred concurrent chemoradiotherapy with temozolomide (TMZ) and adjuvant TMZ (63.8%) than radiotherapy alone (34.0%). In the survey about meningioma, respondents prefer wait-and-see policy for the asymptomatic small meningioma without peritumoral edema. However, a greater number of respondents had chosen surgical resection as the first choice for all large size meningiomas without exception, and small size meningiomas with either peritumoral edema or eloquent location. There was no single opinion with major consensus on long-term follow-up plans for asymptomatic meningioma with observation policy. As many as 68.1% of respondents answered that they would not add any adjuvant therapies for World Health Organization grade II meningiomas if the tumor was totally resected including dura. Conclusion The survey demonstrates the prevailing clinical practice patterns for patients with diffuse midline glioma and meningioma among members of the KSNO. This information provides a point of reference for establishing a practical guideline in the management of diffuse midline glioma and meningioma. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한뇌종양학회 | - |
dc.title | A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, Myun Hoon | - |
dc.identifier.doi | 10.14791/btrt.2020.8.e6 | - |
dc.identifier.bibliographicCitation | Brain Tumor Research and Treatment, v.8, no.1, pp.11 - 19 | - |
dc.relation.isPartOf | Brain Tumor Research and Treatment | - |
dc.citation.title | Brain Tumor Research and Treatment | - |
dc.citation.volume | 8 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 11 | - |
dc.citation.endPage | 19 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002580005 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Korean Society for Neuro-Oncology | - |
dc.subject.keywordAuthor | Practice patterns | - |
dc.subject.keywordAuthor | Brain tumors | - |
dc.subject.keywordAuthor | Diffuse midline glioma | - |
dc.subject.keywordAuthor | Meningioma | - |
dc.subject.keywordAuthor | Guideline Working Group. | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221470/ | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.